일본의 3D 바이오프린팅 시장 보고서 : 컴포넌트, 용도, 최종사용자, 지역별(2025-2033년)

Japan 3D bioprinting market size reached USD 82.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 316.7 Million by 2033, exhibiting a growth rate (CAGR) of 16.1% during 2025-2033. The elevating need for organ transplantation among the geriatric population, along with the easy access to medical technologies, is primarily driving the market growth.

Three-dimensional (3D) bioprinting is an additive manufacturing technique developed for the precise fabrication of anatomical tissues. This method encompasses various deposition and assembly processes, including direct and laser writing, microstamping, photolithography, stereolithography, electro-printing, and inkjet deposition. In addition to this, it relies on the layer-by-layer assembly of cell-based bio-inks, which are formulated using living cells, biomaterials, and active biomolecules, to construct 3D tissue and organ structures. By depositing multiple layers of biomaterials, 3D bioprinting can create complex bodily structures such as bones, skin, cartilage, vascular grafts, tracheal splints, and heart tissues. Consequently, it finds extensive applications in hospitals, research institutions, academic establishments, and biopharmaceutical companies across Japan.

Japan 3D Bioprinting Market Trends:

In the context of the Japan market, the increasing emphasis on reducing animal testing is a significant factor positively influencing the industry. Additionally, the rising demand for 3D bioprinting, particularly among the elderly population who are more susceptible to various chronic illnesses, is fostering a favorable market outlook, thereby acting as another significant growth-inducing factor. Besides this, technological advancements such as the development of organ-on-a-chip systems are also driving market growth. Furthermore, the surging global demand for regenerative medicines, cancer therapeutics, and stem cell solutions is contributing to the expansion of the market. Apart from this, the healthcare sector in Japan is increasingly adopting 3D bioprinting, and its relatively lower disruption level compared to other industries is providing substantial support to market growth. Moreover, prominent manufacturers are placing a strong focus on research and development (R&D) activities aimed at introducing bio printed tissues, which is positively influencing the regional market. This effort aims to reduce the cost associated with new innovations and streamline the drug discovery process, further propelling advancement within Japan. All these above mentioned factors are expected to catalyze the market growth over the forecasted period.

Japan 3D Bioprinting Market Segmentation:

Component Insights:

• 3D Bioprinters
• Syringe/Extrusion Bioprinting
• Inkjet Bioprinting
• Magnetic Levitation Bioprinting
• Laser-assisted Bioprinting
• Others
• Scaffolds
• Biomaterials
• Living Cells
• Hydrogels
• Extracellular Matrices
• Others

Application Insights:

• Research
• Drug Research
• Regenerative Medicine
• 3D Cell Culture
• Clinical
• Skin
• Bone and Cartilage
• Blood Vessels
• Others

End User Insights:

• Hospitals
• Research Organization and Academic Institutes
• Biopharmaceuticals Companies

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan 3D bioprinting market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan 3D bioprinting market?
• What is the breakup of the Japan 3D bioprinting market on the basis of component?
• What is the breakup of the Japan 3D bioprinting market on the basis of application?
• What is the breakup of the Japan 3D bioprinting market on the basis of end user?
• What are the various stages in the value chain of the Japan 3D bioprinting market?
• What are the key driving factors and challenges in the Japan 3D bioprinting?
• What is the structure of the Japan 3D bioprinting market and who are the key players?
• What is the degree of competition in the Japan 3D Bioprinting market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan 3D Bioprinting Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan 3D Bioprinting Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan 3D Bioprinting Market - Breakup by Component

• 6.1 3D Bioprinters
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Segmentation
    • 6.1.3.1 Syringe/Extrusion Bioprinting
    • 6.1.3.2 Inkjet Bioprinting
    • 6.1.3.3 Magnetic Levitation Bioprinting
    • 6.1.3.4 Laser-assisted Bioprinting
    • 6.1.3.5 Others
  • 6.1.4 Market Forecast (2025-2033)
• 6.2 Scaffolds
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Biomaterials
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Segmentation
    • 6.3.3.1 Living Cells
    • 6.3.3.2 Hydrogels
    • 6.3.3.3 Extracellular Matrices
    • 6.3.3.4 Others
  • 6.3.4 Market Forecast (2025-2033)

7 Japan 3D Bioprinting Market - Breakup by Application

• 7.1 Research
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Segmentation
    • 7.1.3.1 Drug Research
    • 7.1.3.2 Regenerative Medicine
    • 7.1.3.3 3D Cell Culture
  • 7.1.4 Market Forecast (2025-2033)
• 7.2 Clinical
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Segmentation
    • 7.2.3.1 Skin
    • 7.2.3.2 Bone and Cartilage
    • 7.2.3.3 Blood Vessels
    • 7.2.3.4 Others
  • 7.2.4 Market Forecast (2025-2033)

8 Japan 3D Bioprinting Market - Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Research Organization and Academic Institutes
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Biopharmaceuticals Companies
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)

8 Japan 3D Bioprinting Market - Competitive Landscape

• 8.1 Overview
• 8.2 Market Structure
• 8.3 Market Player Positioning
• 8.4 Top Winning Strategies
• 8.5 Competitive Dashboard
• 8.6 Company Evaluation Quadrant

9 Profiles of Key Players

• 9.1 Company A
  • 9.1.1 Business Overview
  • 9.1.2 Product Portfolio
  • 9.1.3 Business Strategies
  • 9.1.4 SWOT Analysis
  • 9.1.5 Major News and Events
• 9.2 Company B
  • 9.2.1 Business Overview
  • 9.2.2 Product Portfolio
  • 9.2.3 Business Strategies
  • 9.2.4 SWOT Analysis
  • 9.2.5 Major News and Events
• 9.3 Company C
  • 9.3.1 Business Overview
  • 9.3.2 Product Portfolio
  • 9.3.3 Business Strategies
  • 9.3.4 SWOT Analysis
  • 9.3.5 Major News and Events
• 9.4 Company D
  • 9.4.1 Business Overview
  • 9.4.2 Product Portfolio
  • 9.4.3 Business Strategies
  • 9.4.4 SWOT Analysis
  • 9.4.5 Major News and Events
• 9.5 Company E
  • 9.5.1 Business Overview
  • 9.5.2 Product Portfolio
  • 9.5.3 Business Strategies
  • 9.5.4 SWOT Analysis
  • 9.5.5 Major News and Events

10 Japan 3D Bioprinting Market - Industry Analysis

• 10.1 Drivers, Restraints, and Opportunities
  • 10.1.1 Overview
  • 10.1.2 Drivers
  • 10.1.3 Restraints
  • 10.1.4 Opportunities
• 10.2 Porters Five Forces Analysis
  • 10.2.1 Overview
  • 10.2.2 Bargaining Power of Buyers
  • 10.2.3 Bargaining Power of Suppliers
  • 10.2.4 Degree of Competition
  • 10.2.5 Threat of New Entrants
  • 10.2.6 Threat of Substitutes
• 10.3 Value Chain Analysis

11 Appendix